{"id":53408,"date":"2023-01-30T14:03:08","date_gmt":"2023-01-30T13:03:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/"},"modified":"2023-01-30T14:03:08","modified_gmt":"2023-01-30T13:03:08","slug":"metafora-launches-metaflow-its-digital-cytometry-analysis-platform","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/","title":{"rendered":"METAFORA Launches METAflow, its Digital Cytometry Analysis Platform"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Launch in Europe &amp; U.S. for limited number of RUO licensees<\/b>\n<\/li>\n<li>\n<b>Global launch expected later in spring<\/b>\n<\/li>\n<\/ul>\n<p>PARIS &amp; CHICAGO&#8211;(BUSINESS WIRE)&#8211;<b>METAFORA biosystems, today announces the launch of METAflow, its digital flow cytometry platform, into the RUO market. METAflow offers the power of a highly advanced unsupervised algorithm suite through a simple, elegant workflow accessible to any user, from beginners to advanced users. A cloud-based software enabling automated multidimensional clustering of flow cytometry data, METAflow marks a dramatic advance over existing, suboptimal solutions, regardless of data processing skills.<\/b>\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230130005014\/en\/1697130\/5\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230130005014\/en\/1697130\/21\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg\"><\/a><\/p>\n<p>\nVincent Petit, CEO of Metafora, said, \u201cScientists and biologists today analyze flow cytometry data either manually, through a so-called gating strategy, or through a mix of manual data preprocessing and the implementation of a series of algorithms. Multiple trial and error runs are required before finding the right settings, and getting relevant results. In contrast, METAflow offers a faster, more robust and intuitive way to reach the desired populations. We look forward to rolling out METAflow to at first a limited number of RUO licensees, and setting the stage for accessing the research community at large later this spring.\u201d\n<\/p>\n<p>\nStarting today, a limited number of licensees from Europe and the U.S. will start working with METAflow. The feedback of these first customers will serve to prepare for the global roll-out of METAflow in spring, while simultaneously scaling the support team of application and digital specialists and the opening a U.S. office.\n<\/p>\n<p>\n<b>About METAflow<\/b>\n<\/p>\n<p>\nMETAflow is a flow cytometry data analysis software with unmatched robustness and a seamless, comprehensive, user-friendly interface. Metafora believes that METAflow will allow hundreds of thousands of flow cytometrists to move from cumbersome sequential manual gating to automated multidimensional clustering to obtain more objective data in a much shorter timeframe. METAflow provides objective, reproducible, traceable results, all in a collaborative digital platform that empowers users to mine and retrieve the best from increasing data sets generated by conventional, mass or spectral cytometry.\n<\/p>\n<p>\nAfter a successful features\u2019 showcase during CYTO22 and ESSCA conferences, and a year of continuous development through an early access program, METAflow is now ready to enter the RUO market. To go beyond the RUO market, Metafora is developing, partly financed through the EIC Accelerator Program, a clinical grade version for use in clinical research and in routine settings.\n<\/p>\n<p>\n<b>About Metafora<\/b>\n<\/p>\n<p>\nMETAFORA biosystems has developed METAflow, a flow cytometry data analysis software with unmatched robustness and a user-friendly interface that yields objective, reproducible, and actionable results from the increasingly large and unwieldy data sets generated by conventional, mass or spectral cytometry.\n<\/p>\n<p>\nMETAflow in combination with Metafora\u2019s proprietary reagents underpins METAbolism, the company\u2019s IVD activity. METAglut1 is a first diagnostic test for the early diagnosis of De Vivo disease, a rare pediatric neurometabolic disorder. The company is developing a number of oncology diagnostics as well as a solution to increase the clinical efficacy of cell therapies and reduce manufacturing costs.\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.metafora-biosystems.com&amp;esheet=53291625&amp;newsitemid=20230130005014&amp;lan=en-US&amp;anchor=www.metafora-biosystems.com&amp;index=1&amp;md5=fd56c6b97b50ac8b677e00429a68a496\" rel=\"nofollow noopener\" shape=\"rect\">www.metafora-biosystems.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>For further information, please contact:<\/b><br \/>Vincent Petit, CEO<br \/>\n<br \/>Phone: +33-6-76-71-61-14<br \/>\n<br \/>Email: <a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;to&#x3a;&#x76;&#x69;&#110;ce&#x6e;&#x74;&#x2e;&#112;&#101;t&#x69;&#x74;&#x40;&#109;&#101;t&#x61;&#x66;&#x6f;&#114;&#97;-b&#x69;&#x6f;&#x73;&#121;st&#x65;&#x6d;&#x73;&#46;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">vi&#110;&#99;&#101;&#110;&#x74;&#x2e;&#x70;&#x65;&#x74;it&#64;&#109;&#101;&#116;&#x61;&#x66;&#x6f;&#x72;&#x61;-b&#105;&#111;&#115;&#121;&#x73;&#x74;&#x65;&#x6d;&#x73;&#46;co&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Launch in Europe &amp; U.S. for limited number of RUO licensees Global launch expected later in spring PARIS &amp; CHICAGO&#8211;(BUSINESS WIRE)&#8211;METAFORA biosystems, today announces the launch of METAflow, its digital flow cytometry platform, into the RUO market. METAflow offers the power of a highly advanced unsupervised algorithm suite through a simple, elegant workflow accessible to &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53408","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>METAFORA Launches METAflow, its Digital Cytometry Analysis Platform - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"METAFORA Launches METAflow, its Digital Cytometry Analysis Platform - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Launch in Europe &amp; U.S. for limited number of RUO licensees Global launch expected later in spring PARIS &amp; CHICAGO&#8211;(BUSINESS WIRE)&#8211;METAFORA biosystems, today announces the launch of METAflow, its digital flow cytometry platform, into the RUO market. METAflow offers the power of a highly advanced unsupervised algorithm suite through a simple, elegant workflow accessible to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-30T13:03:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230130005014\/en\/1697130\/21\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"METAFORA Launches METAflow, its Digital Cytometry Analysis Platform\",\"datePublished\":\"2023-01-30T13:03:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/\"},\"wordCount\":519,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005014\\\/en\\\/1697130\\\/21\\\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/\",\"name\":\"METAFORA Launches METAflow, its Digital Cytometry Analysis Platform - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005014\\\/en\\\/1697130\\\/21\\\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg\",\"datePublished\":\"2023-01-30T13:03:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005014\\\/en\\\/1697130\\\/21\\\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005014\\\/en\\\/1697130\\\/21\\\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"METAFORA Launches METAflow, its Digital Cytometry Analysis Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"METAFORA Launches METAflow, its Digital Cytometry Analysis Platform - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/","og_locale":"en_US","og_type":"article","og_title":"METAFORA Launches METAflow, its Digital Cytometry Analysis Platform - Pharma Trend","og_description":"Launch in Europe &amp; U.S. for limited number of RUO licensees Global launch expected later in spring PARIS &amp; CHICAGO&#8211;(BUSINESS WIRE)&#8211;METAFORA biosystems, today announces the launch of METAflow, its digital flow cytometry platform, into the RUO market. METAflow offers the power of a highly advanced unsupervised algorithm suite through a simple, elegant workflow accessible to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-30T13:03:08+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230130005014\/en\/1697130\/21\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"METAFORA Launches METAflow, its Digital Cytometry Analysis Platform","datePublished":"2023-01-30T13:03:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/"},"wordCount":519,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230130005014\/en\/1697130\/21\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/","url":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/","name":"METAFORA Launches METAflow, its Digital Cytometry Analysis Platform - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230130005014\/en\/1697130\/21\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg","datePublished":"2023-01-30T13:03:08+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230130005014\/en\/1697130\/21\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230130005014\/en\/1697130\/21\/METAFORA_METAflow_Product-Logo_ByMETAFORA-%28002%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/metafora-launches-metaflow-its-digital-cytometry-analysis-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"METAFORA Launches METAflow, its Digital Cytometry Analysis Platform"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53408"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53408\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}